by A recent study conducted by researchers at Georgia Tech has shed light on the role that genetics play in the risk of developing inflammatory bowel disease (IBD) in African Americans. The study, led by Greg Gibson, highlights the importance of considering genetic diversity and admixture in genetics research.
The advent of whole genome sequencing technology has revolutionized the field of genetics research, allowing researchers to explore the relationship between genetics and disease risk. However, the majority of genetics research has been conducted on individuals of European ancestry, leading to a lack of understanding of how genetics impact different populations. In order to address health disparities, it is crucial to include diverse populations in genetics research.
In the study, the researchers investigated whether 25 rare gene variants known to be associated with inflammatory bowel disease in individuals of European ancestry also played a role in the risk for African Americans. The researchers analyzed the complete genome sequences of over 3,000 African American individuals, half of whom had IBD. They found that the rare variants had a significantly reduced prevalence in African Americans compared to European Americans, indicating that they made a smaller contribution to IBD risk in African Americans.
Further analysis using a method called chromosome painting revealed that the rare variants found in African Americans were mainly located on segments of European ancestry genomes. This suggests that the variants arose through admixture, the mixing of genetic backgrounds throughout ancestry, and only began to appear in people of African ancestry in the last several generations.
The findings of the study have important implications for genetics research and precision medicine. They highlight the need to consider genetic diversity and admixture in all genetics research, particularly when investigating rare variants and their associations with complex diseases. The study also emphasizes that genetics is not the sole factor contributing to the risk of complex diseases like IBD, and that social determinants of health should also be taken into consideration.
The researchers stress the importance of conducting more genetic studies on diverse populations, especially those with admixture. This will be crucial for therapeutic discovery and the development of personalized medicine based on an individual’s genome. Without including diverse populations in research, new treatments may not be effective for everyone.
In conclusion, the study conducted by Georgia Tech researchers highlights the significance of genetic diversity and admixture in genetics research. It underscores the need to include diverse populations in studies to ensure equitable healthcare outcomes. By conducting large-scale genetic sequencing for African Americans and other ancestry groups, researchers can gain a better understanding of genetic variants and their implications for disease risk, leading to advancements in precision medicine and improved healthcare for all.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
